Chimeric Therapeutics Ltd (CHM) — Defensive Interval Ratio
Chimeric Therapeutics Ltd (CHM) has a Defensive Interval Ratio of 249 days as of December 2025. Defensive assets of AU$5.04 Million (cash AU$2.50 Million, short-term investments AU$-, receivables AU$2.53 Million) cover 249 days of daily cash needs of AU$20.23K/day. See Chimeric Therapeutics Ltd (CHM) liquidity to equity ratio to evaluate short-term liquidity relative to the company's equity base.
Defensive Interval Ratio
Defensive Assets
Daily Cash Need
Current Liabilities
Chimeric Therapeutics Ltd Defensive Interval Ratio (2021–2025)
This chart shows how Chimeric Therapeutics Ltd's Defensive Interval Ratio has evolved across 5 annual periods from 2021 to 2025. As of December 2025, the ratio stands at 249 days, meaning defensive assets of AU$5.04 Million can fund 249 days of operations without new revenue. See Chimeric Therapeutics Ltd balance sheet quality to measure how much of total assets are equity-financed.
Annual Defensive Interval Ratio for Chimeric Therapeutics Ltd (2021–2025)
The table below presents the year-by-year Defensive Interval Ratio for Chimeric Therapeutics Ltd from 2021 to 2025, covering 5 annual filings. Each row shows defensive assets, daily cash need, the DIR in days, and the change in days compared to the prior year. For live market cap and the full company financial profile, see Chimeric Therapeutics Ltd (CHM) market capitalisation.
| Year | DIR (days) | Defensive Assets (AUD) | Daily Cash Need | Cash | ST Investments | Change (days) |
|---|---|---|---|---|---|---|
| 2025 | 114 days | AU$4.55 Million | AU$40.04K/day | AU$- | AU$- | ▲ +111 days |
| 2024 | 3 days | AU$86.59K | AU$27.66K/day | AU$- | AU$- | ▼ -88 days |
| 2023 | 91 days | AU$3.65 Million | AU$40.25K/day | AU$- | AU$- | ▼ -761 days |
| 2022 | 851 days | AU$21.04 Million | AU$24.71K/day | AU$18.38 Million | AU$- | ▼ -262 days |
| 2021 | 1113 days | AU$22.43 Million | AU$20.15K/day | AU$22.41 Million | AU$- | — |